THE INVESTOR

메뉴열기
April 19, 2024

Feelux acquires US drug developers at W38b

PUBLISHED : April 16, 2018 - 12:04

UPDATED : April 16, 2018 - 12:04

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • sms

[DISCLOSURE] Feelux (033180) announced on April 13 that it has acquired 100 percent stakes in TJU Asset Management and Penn Life Science at 37.8 billion won (US$35.24 million). 

By Hwang You-mee (glamazon@heraldcorp.com)

  • 페이스북
  • sms
최상단으로
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.